ICD-10-PCS Table
3E0
Administration, Physiological Systems and Anatomical Regions, Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
1064 codes total in this table
Axis Grid
Body System / Region
- 0Skin and Mucous Membranes
Approach
- XExternal
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- 0Skin and Mucous Membranes
Approach
- XExternal
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 0Skin and Mucous Membranes
Approach
- XExternal
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- BAnesthetic Agent
- KOther Diagnostic Substance
- MPigment
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- 0Skin and Mucous Membranes
Approach
- XExternal
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- 1Subcutaneous Tissue
Approach
- 0Open
Substance
- 2Anti-infective
Qualifier
- AAnti-Infective Envelope
1 code in this combination
Body System / Region
- 1Subcutaneous Tissue
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- 1Subcutaneous Tissue
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
- AAnti-Infective Envelope
Body System / Region
- 1Subcutaneous Tissue
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- 1Subcutaneous Tissue
Approach
- 3Percutaneous
Substance
- 4Serum, Toxoid and Vaccine
Qualifier
- 0Influenza Vaccine
- ZNo Qualifier
Body System / Region
- 1Subcutaneous Tissue
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- 1Subcutaneous Tissue
Approach
- 3Percutaneous
Substance
- VHormone
Qualifier
- GInsulin
- JOther Hormone
Body System / Region
- 2Muscle
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- 2Muscle
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 2Muscle
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- 2Muscle
Approach
- 3Percutaneous
Substance
- 4Serum, Toxoid and Vaccine
Qualifier
- 0Influenza Vaccine
- ZNo Qualifier
Body System / Region
- 2Muscle
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 5Other Antineoplastic
- MMonoclonal Antibody
- PClofarabine
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- 1Thrombolytic
Qualifier
- 6Recombinant Human-activated Protein C
- 7Other Thrombolytic
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- FIntracirculatory Anesthetic
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- PPlatelet Inhibitor
- RAntiarrhythmic
- TDestructive Agent
- XVasopressor
Qualifier
- ZNo Qualifier
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
- NBlood Brain Barrier Disruption
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- UPancreatic Islet Cells
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- VHormone
Qualifier
- GInsulin
- HHuman B-type Natriuretic Peptide
- JOther Hormone
Body System / Region
- 3Peripheral Vein
Approach
- 0Open
Substance
- WImmunotherapeutic
Qualifier
- KImmunostimulator
- LImmunosuppressive
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 5Other Antineoplastic
- MMonoclonal Antibody
- PClofarabine
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- 1Thrombolytic
Qualifier
- 6Recombinant Human-activated Protein C
- 7Other Thrombolytic
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- AStem Cells, Embryonic
- FIntracirculatory Anesthetic
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- PPlatelet Inhibitor
- RAntiarrhythmic
- TDestructive Agent
- XVasopressor
Qualifier
- ZNo Qualifier
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
- NBlood Brain Barrier Disruption
- QGlucarpidase
- ROther Therapeutic Monoclonal Antibody
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- UPancreatic Islet Cells
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- VHormone
Qualifier
- GInsulin
- HHuman B-type Natriuretic Peptide
- JOther Hormone
Body System / Region
- 3Peripheral Vein
Approach
- 3Percutaneous
Substance
- WImmunotherapeutic
Qualifier
- KImmunostimulator
- LImmunosuppressive
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 5Other Antineoplastic
- MMonoclonal Antibody
- PClofarabine
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- 1Thrombolytic
Qualifier
- 6Recombinant Human-activated Protein C
- 7Other Thrombolytic
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- FIntracirculatory Anesthetic
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- PPlatelet Inhibitor
- RAntiarrhythmic
- TDestructive Agent
- XVasopressor
Qualifier
- ZNo Qualifier
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
- NBlood Brain Barrier Disruption
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- VHormone
Qualifier
- GInsulin
- HHuman B-type Natriuretic Peptide
- JOther Hormone
Body System / Region
- 4Central Vein
Approach
- 0Open
Substance
- WImmunotherapeutic
Qualifier
- KImmunostimulator
- LImmunosuppressive
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 5Other Antineoplastic
- MMonoclonal Antibody
- PClofarabine
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- 1Thrombolytic
Qualifier
- 6Recombinant Human-activated Protein C
- 7Other Thrombolytic
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- AStem Cells, Embryonic
- FIntracirculatory Anesthetic
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- PPlatelet Inhibitor
- RAntiarrhythmic
- TDestructive Agent
- XVasopressor
Qualifier
- ZNo Qualifier
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
- NBlood Brain Barrier Disruption
- QGlucarpidase
- ROther Therapeutic Monoclonal Antibody
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- VHormone
Qualifier
- GInsulin
- HHuman B-type Natriuretic Peptide
- JOther Hormone
Body System / Region
- 4Central Vein
Approach
- 3Percutaneous
Substance
- WImmunotherapeutic
Qualifier
- KImmunostimulator
- LImmunosuppressive
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 5Other Antineoplastic
- MMonoclonal Antibody
- PClofarabine
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- 1Thrombolytic
Qualifier
- 6Recombinant Human-activated Protein C
- 7Other Thrombolytic
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- FIntracirculatory Anesthetic
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- PPlatelet Inhibitor
- RAntiarrhythmic
- TDestructive Agent
- XVasopressor
Qualifier
- ZNo Qualifier
48 codes in this combination
3E0503Z3E0504Z3E0506Z3E0507Z3E050FZ3E050HZ3E050KZ3E050NZ3E050PZ3E050RZ3E050TZ3E050XZ3E0533Z3E0534Z3E0536Z3E0537Z3E053FZ3E053HZ3E053KZ3E053NZ3E053PZ3E053RZ3E053TZ3E053XZ3E0603Z3E0604Z3E0606Z3E0607Z3E060FZ3E060HZ3E060KZ3E060NZ3E060PZ3E060RZ3E060TZ3E060XZ3E0633Z3E0634Z3E0636Z3E0637Z3E063FZ3E063HZ3E063KZ3E063NZ3E063PZ3E063RZ3E063TZ3E063XZ
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
- NBlood Brain Barrier Disruption
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- VHormone
Qualifier
- GInsulin
- HHuman B-type Natriuretic Peptide
- JOther Hormone
Body System / Region
- 5Peripheral Artery
- 6Central Artery
Approach
- 0Open
- 3Percutaneous
Substance
- WImmunotherapeutic
Qualifier
- KImmunostimulator
- LImmunosuppressive
Body System / Region
- 7Coronary Artery
- 8Heart
Approach
- 0Open
- 3Percutaneous
Substance
- 1Thrombolytic
Qualifier
- 6Recombinant Human-activated Protein C
- 7Other Thrombolytic
Body System / Region
- 7Coronary Artery
- 8Heart
Approach
- 0Open
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- 7Coronary Artery
- 8Heart
Approach
- 0Open
- 3Percutaneous
Substance
- KOther Diagnostic Substance
- PPlatelet Inhibitor
Qualifier
- ZNo Qualifier
Body System / Region
- 7Coronary Artery
- 8Heart
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- 9Nose
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- 9Nose
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- 9Nose
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- 9Nose
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- ABone Marrow
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- ABone Marrow
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- BEar
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- BEar
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- BEar
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 3Anti-inflammatory
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- BEar
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- CEye
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- CEye
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- CEye
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 3Anti-inflammatory
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- MPigment
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- CEye
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- CEye
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- SGas
Qualifier
- FOther Gas
Body System / Region
- DMouth and Pharynx
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- DMouth and Pharynx
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- DMouth and Pharynx
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- 3Anti-inflammatory
- 4Serum, Toxoid and Vaccine
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- RAntiarrhythmic
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- DMouth and Pharynx
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- XExternal
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- EProducts of Conception
- GUpper GI
- HLower GI
- KGenitourinary Tract
- NMale Reproductive
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
45 codes in this combination
3E0E3043E0E3053E0E30M3E0E7043E0E7053E0E70M3E0E8043E0E8053E0E80M3E0G3043E0G3053E0G30M3E0G7043E0G7053E0G70M3E0G8043E0G8053E0G80M3E0H3043E0H3053E0H30M3E0H7043E0H7053E0H70M3E0H8043E0H8053E0H80M3E0K3043E0K3053E0K30M3E0K7043E0K7053E0K70M3E0K8043E0K8053E0K80M3E0N3043E0N3053E0N30M3E0N7043E0N7053E0N70M3E0N8043E0N8053E0N80M
Body System / Region
- EProducts of Conception
- GUpper GI
- HLower GI
- KGenitourinary Tract
- NMale Reproductive
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- EProducts of Conception
- GUpper GI
- HLower GI
- KGenitourinary Tract
- NMale Reproductive
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
120 codes in this combination
3E0E33Z3E0E36Z3E0E37Z3E0E3BZ3E0E3HZ3E0E3KZ3E0E3NZ3E0E3TZ3E0E73Z3E0E76Z3E0E77Z3E0E7BZ3E0E7HZ3E0E7KZ3E0E7NZ3E0E7TZ3E0E83Z3E0E86Z3E0E87Z3E0E8BZ3E0E8HZ3E0E8KZ3E0E8NZ3E0E8TZ3E0G33Z3E0G36Z3E0G37Z3E0G3BZ3E0G3HZ3E0G3KZ3E0G3NZ3E0G3TZ3E0G73Z3E0G76Z3E0G77Z3E0G7BZ3E0G7HZ3E0G7KZ3E0G7NZ3E0G7TZ3E0G83Z3E0G86Z3E0G87Z3E0G8BZ3E0G8HZ3E0G8KZ3E0G8NZ3E0G8TZ3E0H33Z3E0H36Z3E0H37Z3E0H3BZ3E0H3HZ3E0H3KZ3E0H3NZ3E0H3TZ3E0H73Z3E0H76Z3E0H77Z3E0H7BZ3E0H7HZ3E0H7KZ3E0H7NZ3E0H7TZ3E0H83Z3E0H86Z3E0H87Z3E0H8BZ3E0H8HZ3E0H8KZ3E0H8NZ3E0H8TZ3E0K33Z3E0K36Z3E0K37Z3E0K3BZ3E0K3HZ3E0K3KZ3E0K3NZ3E0K3TZ3E0K73Z3E0K76Z3E0K77Z3E0K7BZ3E0K7HZ3E0K7KZ3E0K7NZ3E0K7TZ3E0K83Z3E0K86Z3E0K87Z3E0K8BZ3E0K8HZ3E0K8KZ3E0K8NZ3E0K8TZ3E0N33Z3E0N36Z3E0N37Z3E0N3BZ3E0N3HZ3E0N3KZ3E0N3NZ3E0N3TZ3E0N73Z3E0N76Z3E0N77Z3E0N7BZ3E0N7HZ3E0N7KZ3E0N7NZ3E0N7TZ3E0N83Z3E0N86Z3E0N87Z3E0N8BZ3E0N8HZ3E0N8KZ3E0N8NZ3E0N8TZ
Body System / Region
- EProducts of Conception
- GUpper GI
- HLower GI
- KGenitourinary Tract
- NMale Reproductive
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- EProducts of Conception
- GUpper GI
- HLower GI
- KGenitourinary Tract
- NMale Reproductive
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- SGas
Qualifier
- FOther Gas
Body System / Region
- EProducts of Conception
- GUpper GI
- HLower GI
- KGenitourinary Tract
- NMale Reproductive
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- FRespiratory Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- FRespiratory Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- FRespiratory Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- FRespiratory Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- FRespiratory Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- SGas
Qualifier
- DNitric Oxide
- FOther Gas
Body System / Region
- FRespiratory Tract
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- SGas
Qualifier
- FOther Gas
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 3Percutaneous
- 7Via Natural or Artificial Opening
- 8Via Natural or Artificial Opening Endoscopic
Substance
- UPancreatic Islet Cells
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- JBiliary and Pancreatic Tract
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 0Open
Substance
- 5Adhesion Barrier
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- LPleural Cavity
Approach
- 3Percutaneous
Substance
- 1Thrombolytic
Qualifier
- 7Other Thrombolytic
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- LPleural Cavity
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 5Adhesion Barrier
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- LPleural Cavity
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 4Percutaneous Endoscopic
Substance
- 5Adhesion Barrier
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- LPleural Cavity
Approach
- 7Via Natural or Artificial Opening
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- LPleural Cavity
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- MPeritoneal Cavity
Approach
- 0Open
Substance
- 5Adhesion Barrier
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- MPeritoneal Cavity
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
- YHyperthermic
Body System / Region
- MPeritoneal Cavity
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- MPeritoneal Cavity
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 5Adhesion Barrier
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- MPeritoneal Cavity
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- MPeritoneal Cavity
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- MPeritoneal Cavity
Approach
- 4Percutaneous Endoscopic
Substance
- 5Adhesion Barrier
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- MPeritoneal Cavity
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- MPeritoneal Cavity
Approach
- 7Via Natural or Artificial Opening
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- MPeritoneal Cavity
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 0Open
Substance
- 5Adhesion Barrier
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- PFemale Reproductive
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- PFemale Reproductive
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 5Adhesion Barrier
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- LSperm
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
- VHormone
Qualifier
- ZNo Qualifier
Body System / Region
- PFemale Reproductive
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 3Percutaneous
Substance
- QFertilized Ovum
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- PFemale Reproductive
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 4Percutaneous Endoscopic
Substance
- 5Adhesion Barrier
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 7Via Natural or Artificial Opening
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- PFemale Reproductive
Approach
- 7Via Natural or Artificial Opening
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- PFemale Reproductive
Approach
- 7Via Natural or Artificial Opening
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- LSperm
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
- VHormone
Qualifier
- ZNo Qualifier
Body System / Region
- PFemale Reproductive
Approach
- 7Via Natural or Artificial Opening
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 7Via Natural or Artificial Opening
Substance
- QFertilized Ovum
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- PFemale Reproductive
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- PFemale Reproductive
Approach
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- PFemale Reproductive
Approach
- 8Via Natural or Artificial Opening Endoscopic
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- PFemale Reproductive
Approach
- 8Via Natural or Artificial Opening Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- PFemale Reproductive
Approach
- 8Via Natural or Artificial Opening Endoscopic
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- QCranial Cavity and Brain
Approach
- 0Open
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- QCranial Cavity and Brain
Approach
- 0Open
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- QCranial Cavity and Brain
Approach
- 0Open
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- AStem Cells, Embryonic
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- QCranial Cavity and Brain
Approach
- 0Open
- 3Percutaneous
Substance
- EStem Cells, Somatic
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- QCranial Cavity and Brain
Approach
- 0Open
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- QCranial Cavity and Brain
Approach
- 0Open
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
Body System / Region
- QCranial Cavity and Brain
Approach
- 7Via Natural or Artificial Opening
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- QCranial Cavity and Brain
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- RSpinal Canal
Approach
- 0Open
Substance
- AStem Cells, Embryonic
Qualifier
- ZNo Qualifier
1 code in this combination
Body System / Region
- RSpinal Canal
Approach
- 0Open
Substance
- EStem Cells, Somatic
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- RSpinal Canal
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- RSpinal Canal
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- RSpinal Canal
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- AStem Cells, Embryonic
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- RSpinal Canal
Approach
- 3Percutaneous
Substance
- EStem Cells, Somatic
Qualifier
- 0Autologous
- 1Nonautologous
Body System / Region
- RSpinal Canal
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- RSpinal Canal
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- RSpinal Canal
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- SEpidural Space
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 2High-dose Interleukin-2
- 3Low-dose Interleukin-2
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- SEpidural Space
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- SEpidural Space
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- SEpidural Space
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- SEpidural Space
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- SEpidural Space
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- TPeripheral Nerves and Plexi
- XCranial Nerves
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- BAnesthetic Agent
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- TPeripheral Nerves and Plexi
- XCranial Nerves
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
Body System / Region
- UJoints
Approach
- 0Open
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- UJoints
Approach
- 0Open
Substance
- GOther Therapeutic Substance
Qualifier
- BRecombinant Bone Morphogenetic Protein
- COther Substance
Body System / Region
- UJoints
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- UJoints
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- UJoints
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- UJoints
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- BRecombinant Bone Morphogenetic Protein
- COther Substance
Body System / Region
- UJoints
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- UJoints
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- VBones
Approach
- 0Open
Substance
- GOther Therapeutic Substance
Qualifier
- BRecombinant Bone Morphogenetic Protein
- COther Substance
Body System / Region
- VBones
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- VBones
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- VBones
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- VBones
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- BRecombinant Bone Morphogenetic Protein
- COther Substance
Body System / Region
- VBones
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- WLymphatics
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- WLymphatics
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- WLymphatics
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- WLymphatics
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- YPericardial Cavity
Approach
- 3Percutaneous
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- YPericardial Cavity
Approach
- 3Percutaneous
Substance
- 2Anti-infective
Qualifier
- 8Oxazolidinones
- 9Other Anti-infective
Body System / Region
- YPericardial Cavity
Approach
- 3Percutaneous
Substance
- 3Anti-inflammatory
- 6Nutritional Substance
- 7Electrolytic and Water Balance Substance
- BAnesthetic Agent
- HRadioactive Substance
- KOther Diagnostic Substance
- NAnalgesics, Hypnotics, Sedatives
- TDestructive Agent
Qualifier
- ZNo Qualifier
Body System / Region
- YPericardial Cavity
Approach
- 3Percutaneous
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- YPericardial Cavity
Approach
- 3Percutaneous
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Body System / Region
- YPericardial Cavity
Approach
- 4Percutaneous Endoscopic
Substance
- GOther Therapeutic Substance
Qualifier
- COther Substance
1 code in this combination
Body System / Region
- YPericardial Cavity
Approach
- 7Via Natural or Artificial Opening
Substance
- 0Antineoplastic
Qualifier
- 4Liquid Brachytherapy Radioisotope
- 5Other Antineoplastic
- MMonoclonal Antibody
Body System / Region
- YPericardial Cavity
Approach
- 7Via Natural or Artificial Opening
Substance
- SGas
Qualifier
- FOther Gas
1 code in this combination
Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April). All data sources · How to read the labels